Cost-effectiveness of raloxifene for the prevention of osteoporotic fractures in Australia

被引：0
|
作者：
Davey, PJ
Lees, M
Graham-Clarke, P
机构：
[1] Med Technol Assessment Grp, Chatswood, NSW, Australia
[2] Eli Lilly Australia Pty Ltd, W Ryde, NSW, Australia
来源：
VALUE IN HEALTH | 2003年 / 6卷 / 03期
关键词：
D O I：
10.1016/S1098-3015(10)63913-7
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：224 / 224
页数：1
相关论文
共 50 条
  • [41] Cost-effectiveness of risedronate for the treatment of osteoporosis and prevention of fractures in postmenopausal women
    J. A. Kanis
    F. Borgstrom
    O. Johnell
    B. Jonsson
    Osteoporosis International, 2004, 15 : 862 - 871
  • [42] The cost-effectiveness of calcium and vitamin D or hormone replacement therapy in the prevention of osteoporosis and osteoporotic fractures in Canadian postmenopausal women.
    Papadimitropoulos, EA
    Goeree, R
    Blackhouse, G
    Coyte, P
    Josse, RG
    Adachi, J
    Greenwood, C
    JOURNAL OF BONE AND MINERAL RESEARCH, 2003, 18 : S384 - S384
  • [43] Role of prevention: cost-effectiveness of prevention
    Berrino, F
    ANNALS OF ONCOLOGY, 2004, 15 : 245 - 248
  • [44] Avahan and the cost-effectiveness of "prevention as prevention"
    Marseille, Elliot
    Kahn, James G.
    LANCET GLOBAL HEALTH, 2014, 2 (09): : E493 - E494
  • [45] Improving the cost-effectiveness of cardiovascular disease prevention in Australia: a modelling study
    Linda J Cobiac
    Anne Magnus
    Jan J Barendregt
    Rob Carter
    Theo Vos
    BMC Public Health, 12
  • [46] Improving the cost-effectiveness of cardiovascular disease prevention in Australia: a modelling study
    Cobiac, Linda J.
    Magnus, Anne
    Barendregt, Jan J.
    Carter, Rob
    Vos, Theo
    BMC PUBLIC HEALTH, 2012, 12
  • [47] COST-EFFECTIVENESS OF MULTIPLE ANTI-OSTEOPOROTIC THERAPIES FOR SECONDARY FRACTURE PREVENTION IN JAPAN
    Moriwaki, K.
    Yoshimura, M.
    Izumi, R.
    Noto, S.
    VALUE IN HEALTH, 2014, 17 (07) : A381 - A381
  • [48] Cost-effectiveness of stroke prevention
    Ebrahim, S
    BRITISH MEDICAL BULLETIN, 2000, 56 (02) : 557 - 570
  • [49] COST-EFFECTIVENESS OF ABALOPARATIDE FOLLOWED BY ALENDRONATE IN US WOMEN AND MEN AT HIGH RISK OF OSTEOPOROTIC FRACTURES
    Hiligsmann, M.
    Silverman, S.
    Singer, A. J.
    Pearman, L.
    Wang, Y.
    Caminis, J.
    Reginster, J. Y.
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2023, 35 : S55 - S55
  • [50] Cost-effectiveness of risedronate therapy in postmenopausal women with varying risk of osteoporotic fractures: A Swiss analysis
    Lamy, O
    Krieg, M
    Wasserfalllen, J
    Greiner, R
    Russ, W
    BONE, 2005, 36 : S411 - S411
12345